Staff Attitudes toward Buprenorphine before and after Implementation of an Office-Based Opioid Treatment Program in an Urban Teaching Clinic

被引:2
作者
James, Jocelyn R. [1 ]
Marolf, Marissa [2 ]
Klein, Jared W. [1 ]
Blalock, Kendra L. [1 ]
Merrill, Joseph O. [1 ]
Tsui, Judith, I [1 ]
机构
[1] Univ Washington, Harborview Med Ctr, Dept Med, Div Gen Internal Med,Sch Med, Seattle, WA 98104 USA
[2] Univ Washington, Dept Med, Internal Med Residency Program, Seattle, WA 98104 USA
关键词
Opioid use disorder; buprenorphine; office-based treatment; staff attitudes; PRIMARY-CARE; PHYSICIANS; ADDICTION; BARRIERS; WORKING; STIGMA;
D O I
10.1080/10826084.2021.1928206
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Purpose Improving access to buprenorphine treatment is necessary to address the national opioid use disorder (OUD) crisis. This study investigates attitudes about buprenorphine prescribing among staff at a primary care clinic and compares attitudes before and after implementation of an office-based opioid treatment (OBOT) program. Methods Providers and staff in an academic primary care clinic were surveyed prior to and one year following implementation of an OBOT program. Descriptive statistics, Pearson's Chi-2 tests and logistic regression models were used to compare staff and provider attitudes about use of buprenorphine for OUD and to compare attitudes before and after OBOT implementation. Results At baseline, 20% of staff indicated strong belief that buprenorphine is an effective treatment for OUD and 16% indicated strong belief that primary care providers should prescribe it. Staff appeared less likely than providers to believe strongly that buprenorphine is effective (OR 0.24, 95% CI= 0.08-.78, p = 0.02; aOR 0.28, 95% CI=.08-1.0, p = 0.05 adjusted for age, race and gender). Following implementation of an OBOT program, the percentage of staff who believed strongly in the effectiveness of buprenorphine for OUD increased from 20% to 40% (p = 0.31), and the percentage who believed that primary care providers (PCPs) should prescribe it increased from 16% to 30% (p = 0.52). Conclusions Staff in a primary care clinic were less likely than providers to believe in the effectiveness of buprenorphine treatment or that PCPs should prescribe it for OUD. That their beliefs substantially changed after implementation of an OBOT program suggests that direct experience impacts attitudes.
引用
收藏
页码:1569 / 1575
页数:7
相关论文
共 22 条
  • [1] County-level access to opioid use disorder medications in medicare Part D (2010-2015)
    Abraham, Amanda J.
    Adams, Grace Bagwell
    Bradford, Ashley C.
    Bradford, William D.
    [J]. HEALTH SERVICES RESEARCH, 2019, 54 (02) : 390 - 398
  • [2] Alford DP, 2011, ARCH INTERN MED, V171, P425, DOI 10.1001/archinternmed.2010.541
  • [3] Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians
    Andrilla, C. Holly A.
    Moore, Tessa E.
    Patterson, Davis G.
    [J]. JOURNAL OF RURAL HEALTH, 2019, 35 (01) : 113 - 121
  • [4] Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update
    Andrilla, C. Holly A.
    Moore, Tessa E.
    Patterson, Davis G.
    Larson, Eric H.
    [J]. JOURNAL OF RURAL HEALTH, 2019, 35 (01) : 108 - 112
  • [5] [Anonymous], 2019, KEY SUBSTANCE USE ME
  • [6] [Anonymous], 2013, TECHN ASS PUBL TAP S
  • [7] Challenging the Public Stigma of Mental Illness: A Meta-Analysis of Outcome Studies
    Corrigan, Patrick W.
    Morris, Scott B.
    Michaels, Patrick J.
    Rafacz, Jennifer D.
    Ruesch, Nicolas
    [J]. PSYCHIATRIC SERVICES, 2012, 63 (10) : 963 - 973
  • [8] Cunningham CO, 2006, FAM MED, V38, P336
  • [9] DeFlavio JR, 2015, RURAL REMOTE HEALTH, V15
  • [10] A qualitative analysis of interprofessional students? perceptions toward patients with opioid use disorder after a patient panel experience
    Dumenco, Luba
    Monteiro, Kristina
    Collins, Sally
    Stewart, Cynthia
    Berkowitz, Laureen
    Flanigan, Timothy
    Rich, Josiah
    George, Paul
    [J]. SUBSTANCE ABUSE, 2019, 40 (02) : 125 - 131